Your browser doesn't support javascript.
loading
Effects of intranasal oxytocin on fear extinction learning.
Rashidi, Mahmoud; Simon, Joe J; Bertsch, Katja; Wegen, Gerhard Vincent; Ditzen, Beate; Flor, Herta; Grinevich, Valery; Wolf, Robert Christian; Herpertz, Sabine C.
Afiliação
  • Rashidi M; Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany. rashidi.19@osu.edu.
  • Simon JJ; Department of Psychiatry and Behavioral Health, Wexner Medical Center, The Ohio State University, Columbus, OH, USA. rashidi.19@osu.edu.
  • Bertsch K; Department of General Internal Medicine and Psychosomatics, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany.
  • Wegen GV; Department of Psychology, Julius Maximilians University of Wuerzburg, Wuerzburg, Germany.
  • Ditzen B; Department of General Psychiatry, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany.
  • Flor H; Institute of Medical Psychology, Center for Psychosocial Medicine, Heidelberg University, Heidelberg, Germany.
  • Grinevich V; Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Wolf RC; Department of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Herpertz SC; Center for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta, GA, USA.
Article em En | MEDLINE | ID: mdl-39313675
ABSTRACT
Once a threat no longer exists, extinction of conditioned fear becomes adaptive in order to reduce allotted resources towards cues that no longer predict the threat. In anxiety and stress disorders, fear extinction learning may be affected. Animal findings suggest that the administration of oxytocin (OT) modulates extinction learning in a timepoint-dependent manner, facilitating extinction when administered prior to fear conditioning, but impairing it when administered prior to extinction learning. The aim of the present study was to examine if these findings translate into human research. Using a randomized, double-blind, placebo-controlled, 2-day fear conditioning and extinction learning design, behavioral (self-reported anxiety), physiological (skin conductance response), neuronal (task-based and resting-state functional magnetic resonance imaging), and hormonal (cortisol) data were collected from 124 naturally cycling (taking no hormonal contraceptives) healthy females. When administered prior to conditioning (Day 1), OT, similar to rodent findings, did not affect fear conditioning, but modulated the intrinsic functional connectivity of the anterior insula immediately after fear conditioning. In contrast to animal findings, OT impaired, not facilitated, extinction learning on the next day and increased anterior insula activity. When administered prior to extinction learning (day 2), OT increased the activity in the bilateral middle temporal gyrus, and similar to animal findings, reduced extinction learning. The current findings suggest that intranasal OT impedes fear extinction learning in humans regardless of the timepoint of administration, providing new insights and directions for future translational research and clinical applications.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article